Denız Can Guven

103PUBLICATIONS
321CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesArtificial life and complex adaptive systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (103)

|Aug 06, 2026
Diabetes Increases Immunotherapy-Related Toxicity but Not Efficacy in Metastatic Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.

|Jul 28, 2026
Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Mar 23, 2026
Artificial intelligence in cancer screening: a narrative review of current evidence and future directions.

Yigit Yazarkan, Gamze Sonmez, Taha Koray Sahin

Pageof 18

Frequent Collaborators

23 joint publications

Taha Koray Sahın

12 joint publications

Hasan Çağrı Yıldırım

12 joint publications

Sercan Aksoy

10 joint publications

Sadettin Kılıçkap